InvestorsHub Logo
Followers 23
Posts 2187
Boards Moderated 0
Alias Born 03/18/2013

Re: Birdbrain Ideas post# 406099

Thursday, 03/23/2023 10:49:30 AM

Thursday, March 23, 2023 10:49:30 AM

Post# of 425927
Bird; I agree with your assessment. My wife’s doctor basically said the same thing to her. Vascepa was too expensive, if you want fish oil just use an OTC brand.

Most of these doctors who think this way haven’t taken the time to do the research.

For example; my care provider is a RN practitioner, she was a believer in Vascepa because a doctor colleague educated her on Vascepa. So, there’s a % of doctors out there who do believe in the science.

It’s re-educating the majority of doctors who don’t believe. There’s sufficient evidence already done (outcome studies) that shows EPA effectiveness. I personally don’t understand what the problem is with the majority of doctors. Only thing I can think of is the price point for Vascepa.

Vascepa’s profit margin is relatively high 70% plus. Don’t you think to be more competitive, Amarin could lower the price? Of course the Generics would follow suit?

It’s all about marketing I’m afraid. Amarin has to bite the bullet and piss off the competition. Ford and GM do it all the time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News